Sleep Apnea and Pulmonary Fibrosis

Jul 12, 2025

Dr. Lisa Lancaster, discussed the relationship between sleep apnea and interstitial lung disease (ILD), particularly idiopathic pulmonary fibrosis (IPF). She explained how poor sleep quality, airway collapse, and oxygen desaturation at night can worsen symptoms, contribute to reflux, and potentially accelerate lung damage. Studies show sleep apnea is highly prevalent in IPF, often without obvious symptoms, and treatment with CPAP can improve quality of life, reduce complications, and possibly extend survival. Dr. Lancaster reviewed diagnostic criteria, treatment options, and practical tips, emphasizing individualized care and multidisciplinary collaboration.
Dr. Lisa Lancaster is a Professor of Medicine at Vanderbilt University Medical Center specializing in interstitial lung disease. She directed Vanderbilt’s ILD program for 25 years and now serves as Chief Medical Officer at Endeavor BioMedicines. A strong patient advocate, she has led groundbreaking research on sleep apnea’s impact in pulmonary fibrosis.

Chapters & Timestamps

  1. Overview of Sleep Apnea and ILD – 3:06
  2. Sleep Quality Issues in Pulmonary Fibrosis – 4:41
  3. Understanding Airway Collapse and Breathing Patterns – 9:12
  4. Risk Factors, Symptoms, and Physical Exam Findings – 11:00
  5. Research Findings on Prevalence in IPF – 19:04
  6. Impact of CPAP on Quality of Life and Survival – 24:00
  7. Mechanisms Linking Sleep Apnea, Reflux, and Lung Injury – 26:35
  8. Treatment Options and Device Considerations – 37:02
Disclaimer
This video is for informational purposes only and is not a substitute for professional medical advice. Always consult your doctor for medical concerns.
The page was last reviewed on September 22, 2025